FAZ-3780
Based on 3 publication(s) in Google Scholar
FAZ-3780 is an inhibitor that binds to the NTF2L domain of G3BP1/2. FAZ-3780 binds to the NTF2L nsP3 of G3BP1 with high affinity, with a Kd of 0.15 μM and a Pep-FRET IC50 of 0.7 μM. FAZ-3780 targets the protein-protein interaction domain of G3BP1/2, and specifically inhibits the co-condensation of G3BP1, caprin 1 and RNA in vitro. FAZ-3780 inhibits stress granule formation and disassembles pre-formed stress granules. FAZ-3780 can be used in studies related to cancer and neurodegenerative diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.68%
- CAS. Nr.: 3036029-78-1
- Formel: C35H50N4O5
- Molecular Weight:606.80
-
Speicherung:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications Citing Use of MedChemExpress (MCE) FAZ-3780
MoreAlle DNA/RNA Synthesis Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
In Vitro
FAZ-3780 (G3Ib) (5-50 μM; 2 h) dose-dependently disrupts the interactions between G3BP1 and endogenous caprin 1 as well as USP10 in U2OS cell lysates[1].
FAZ-3780 (25-50 μM; 2 h) disrupts the interaction between the isolated NTF2L domain of G3BP1 and endogenous caprin 1 and USP10 in HEK293T cell lysates[1].
FAZ-3780 (0.001-100 μM; 70 min) potently inhibits the in vitro co-condensation of human G3BP1, caprin 1 and RNA, with an IC50 of 3.450 μM[1].
FAZ-3780 (5-50 μM; 50 min) inhibits sodium arsenite-induced stress granule formation in U2OS/HeLa G3BP1-GFP cells, rapidly disassembles stress granules, and prevents the localization of TDP-43 to stress granules[1].
FAZ-3780 (5-50 μM; 24 h) exhibits sustained and potent inhibitory activity against sodium arsenite-induced stress granule formation in U2OS cells[1].
FAZ-3780 (50 μM; 50 min) inhibits heat shock-induced stress granule formation in U2OS G3BP1-GFP cells and rapidly disassembles pre-formed heat shock-induced stress granules in cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:U2OS cells stably expressing G3BP1-GFP
-
Concentration:5, 20, 50 μM
-
Incubation Time:2 h
-
Result:Resulted in a dose-dependent reduction of
the interaction between G3BP1 and both endogenous caprin
1 and endogenous USP10.
-
Cell Line:HEK293T cells expressing GFP-NTF2L
-
Concentration:25, 50 μM
-
Incubation Time:2 h
-
Result:Disrupted the interaction of the isolated NTF2L domain of G3BP1 with endogenous caprin 1 and USP10.
-
Cell Line:U2OS/Hela G3BP1-GFP cells
-
Concentration:5, 20, 50 μM
-
Incubation Time:50 min
-
Result:Inhibited sodium arsenite-induced G3BP1-GFP signal.
Inhibited heat shock-induced G3BP1-GFP signal.
Rapidly disassembled preformed sodium arsenite-induced G3BP1-GFP signal.
Rapidly disassembled preformed heat shock-induced G3BP1-GFP signal.
Chemical Information
-
CAS. Nr. 3036029-78-1
-
Appearance Solid
-
Molecular Weight 606.80
-
Formel C35H50N4O5
-
Color White to off-white
-
SMILES
O=C(N[C@H](C)C(N1CCC[C@@H]1C2=CC=CC=C2)=O)[C@@H](NC([C@H](C(C)(C)O)NC(CCC(C)(C)C)=O)=O)[C@@H](C)C3=CC=CC=C3
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Nat Cell Biol
2026 Jun;28(6):1204-1218. PMID: 42174134 -
EMBO J
2024 Dec;43(24):6410-6443. PMID: 39533058 -
bioRxiv
Processing bodies promote lysosomal quality control and cell survival during recovery from lysosomal damage. [Abstract]2025 Aug 30:2025.08.27.672666. PMID: 40909692
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 50 mg/mL (82.40 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Protokoll
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Pull-down
The pull-down assay is an in vitro technique used to detect physical interactions between two or more proteins and an invaluable tool for confirming a predicted protein-protein interaction or identifying novel interacting partners. This method typically involves the use of affinity purification with various wash and elution steps.
-
Immunoprecipitation
Immunoprecipitation (IP) is an experimental method that uses the principle of antibody specific binding to purify and enrich target proteins.
-
Protocol for Bimolecular Fluorescence Complementation (BiFC) Assay
Bimolecular fluorescence complementation detects protein-protein proximity in living or fixed cells by fusing two candidate interaction partners to nonfluorescent N- and C-terminal fragments of a fluorescent protein; when the partners interact or remain close enough, the fluorescent fragments complement, mature, and generate a fluorescent signal at the site of the protein complex. The BiFC readout is fluorescence intensity and subcellular localization of the reconstituted fluorophore, which reflects formation or stabilization of a protein complex rather than direct biochemical binding kinetics; BiFC is therefore useful for mapping where interactions occur in cancer cells, neurons, macrophages, organoid-derived cells, or drug-screening systems, but results should be validated by independent assays such as co-IP or Western blot. BiFC signal formation is delayed by fluorophore maturation and can stabilize otherwise transient complexes, so it is not a real-time reversible interaction assay
-
Co-Immunoprecipitation
Co-immunoprecipitation technology can verify protein interaction based on the specific immune reaction between antibodies and antigens.
-
Protocol for Yeast Two-Hybrid (Y2H) Assay
The yeast two-hybrid assay detects binary protein-protein interactions by separating a transcription factor into a DNA-binding domain fused to a "bait" protein and a transcriptional activation domain fused to a "prey" protein; if bait and prey interact in yeast, the transcription factor is reconstituted and activates reporter genes such as HIS3, ADE2, lacZ, MEL1, or other selectable/readable reporters. The readout is yeast growth on selective medium and/or reporter activity, which reflects proximity-dependent transcriptional activation in the yeast nucleus rather than direct biochemical binding in the original mammalian, tumor, neuronal, macrophage, or organoid context. Because yeast two-hybrid can generate false positives and false negatives, interaction claims should be validated using independent assays such as co-immunoprecipitation, Western blot, immunofluorescence colocalization, BiFC, pull-down, or mammalian two-hybrid assays.
Reinheit & Dokumentation
-
Data Sheet (277 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.6480 mL | 8.2399 mL | 16.4799 mL | 41.1997 mL |
| 5 mM | 0.3296 mL | 1.6480 mL | 3.2960 mL | 8.2399 mL | |
| 10 mM | 0.1648 mL | 0.8240 mL | 1.6480 mL | 4.1200 mL | |
| 15 mM | 0.1099 mL | 0.5493 mL | 1.0987 mL | 2.7466 mL | |
| 20 mM | 0.0824 mL | 0.4120 mL | 0.8240 mL | 2.0600 mL | |
| 25 mM | 0.0659 mL | 0.3296 mL | 0.6592 mL | 1.6480 mL | |
| 30 mM | 0.0549 mL | 0.2747 mL | 0.5493 mL | 1.3733 mL | |
| 40 mM | 0.0412 mL | 0.2060 mL | 0.4120 mL | 1.0300 mL | |
| 50 mM | 0.0330 mL | 0.1648 mL | 0.3296 mL | 0.8240 mL | |
| 60 mM | 0.0275 mL | 0.1373 mL | 0.2747 mL | 0.6867 mL | |
| 80 mM | 0.0206 mL | 0.1030 mL | 0.2060 mL | 0.5150 mL |